USSTOCK.TODAY
Market Closed
Log in Sign up

Eton Pharmaceuticals Announces Q3 Results and Raises Guidance

Earnings Whispers · ·by G4L

ETON
ETON Eton Pharmaceuticals Inc
$64.35 +13.97%
View chart & analysis →
  1. 1Eton Pharmaceuticals reported Q3 GAAP net income per share of $1.06 and revenue of $57.93 million.
  2. 2Eton Pharmaceuticals recorded a 211.8% beat compared to the $0.34 consensus.
  3. 3Eton Pharmaceuticals recorded a 37.2% beat compared to the $42.21 million revenue estimate.

So what's the key point?

Eton Pharmaceuticals earned much more money than experts expected. The company's performance came in higher than its targets, creating a positive situation.

Source Earnings Whispers · View original ↗

Related 3-line summaries

Tenon Medical posts Q2 revenue of $1.3M, up 127% year-over-year ACCESSWIRE +1 · Aug 14Ginkgo Bioworks beats Q3 revenue estimates, advancing autonomous lab strategy Earnings Whispers · 2d agoFive9 reports $323.3 million in revenue with AI revenue growing 91% Earnings Whispers · 2d ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news